“What if we could cure 100 rare diseases in just ten years?” That’s not just a dream. It is the mission of Centogene here in Rostock.
Centogene was founded in 2006. It quickly became a global leader in genetic diagnostics and precision medicine. The company’s headquarters are right here in Rostock. Centogene also has locations in Boston, Berlin and Rotkreuz in Switzerland.
Centogene is dedicated to revolutionizing how rare genetic diseases are diagnosed and treated. Their technology and expertise have led to advancements in the field. From its start, Centogene has become a trusted partner for healthcare professionals worldwide. Centogene continues to push boundaries for personalized and accurate diagnoses.
But what does Centogene actually do? They diagnose, understand, and treat rare diseases. Data is at the core of everything they do. Centogene uses a multi-pronged method. This data-driven approach makes Centogene the leading rare disease company.
Centogene’s diagnostic work extends far beyond Germany. They have diagnosed over 2,500 rare diseases in 100 countries. This is thanks to a network of over 30,000 physicians. Since its founding in 2006, Centogene has been spearheading diagnostic solutions. They have a broad diagnostic testing portfolio for rare diseases. It covers over 19,000 genes using over 10,000 different tests. Together, they are revolutionizing the early detection of rare diseases.
Centogene has a rare disease-centric Biodatabank. It contains data from over 800,000 individuals. This biodatabank is a key resource for understanding rare diseases. Centogene has also collected over 400,000 biosamples.
Since its founding, Centogene has generated insights from its diagnostic business. Through in-house research, they have discovered links between genetic diseases and their effects. Their experts have contributed to over 200 peer-reviewed publications. With their technology and expertise, they help elucidate disease pathways. They identify drug targets and screen candidate drugs.
Centogene works with over 30 pharmaceutical partners. Centogene is pursuing research on three priority diseases. These are Gaucher disease, Niemann-Pick type C, and genetic Parkinson’s. Their mission is to enable the cure of 100 rare diseases in 10 years.
Centogene’s platform includes data that reflects a global population. It includes a biobank of patient blood samples and cell cultures. Centogene believes this is the only platform focused on comprehensive analysis of multi-level data. This improves the understanding of rare hereditary diseases. It allows for better identification and stratification of patients and their diseases. This enables and accelerates discovery, development, and access to orphan drugs.
Centogene integrates technologies with the Biodatabank. This provides analysis to guide precision medicine. Their approach enables diagnosis for patients. It supports physician understanding of disease states. It accelerates drug discovery, development, and commercialization.
Centogene embodies these values in their work. They care, collaborate, innovate, and act with integrity. They deliver excellence in everything they do.
Centogene’s story is one of innovation and dedication. From humble beginnings, they have become a global force in the fight against rare diseases. Their work offers hope to millions of patients and families worldwide. Centogene here in Rostock is a beacon of hope.